| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052784 | The Journal of Urology | 2005 | 7 Pages |
Abstract
There were no statistically significant differences in response rate, progression-free survival or overall survival between KT/H alone and KT/H plus AL treatment in patients with AIPC. The addition of AL to KT/H may increase the response duration with an acceptable safety profile compared with treatment with KT/H alone. However, the addition of AL offers no survival benefit in patients with AIPC.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
WILLIAM D. FIGG, YINONG LIU, PHILIP ARLEN, JAMES GULLEY, SETH M. STEINBERG, DAVID J. LIEWEHR, MICHAEL C. COX, SUOPING ZHAI, SERGE CREMERS, ALLYSON PARR, XIAOWEI YANG, CLARA C. CHEN, ELIZABETH JONES, WILLIAM L. DAHUT,